bioRxiv · 10.1101/2025.03.26.645544
IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases
Abstract
Multi-omic and multimodal datasets with detailed clinical annotations offer significant potential to advance our understanding of inflammatory bowel diseases (IBD), refine diagnostics, and enable personalized therapeutic strategies. In this multi-cohort study, we performed an extensive multi-omic and multimodal analysis of 1,002 clinically annotated patients with IBD and non-IBD controls, incorporating whole-exome and RNA sequencing of normal and inflamed gut tissues, serum proteomics, and histopathological assessments from images of H&E-stained tissue sections. Transcriptomic profiles of normal and inflamed tissues revealed distinct site-specific inflammatory signatures in Crohns disease (CD) and ulcerative colitis (UC). Leveraging serum proteomics, we developed an inflammatory protein severity signature that reflects underlying intestinal molecular inflammation. Furthermore, foundation model-based deep learning accurately predicted histologic disease activity scores from images of H&E-stained intestinal tissue sections, offering a robust tool for clinical evaluation. Our integrative analysis highlights the potential of combining multi-omics and advanced computational approaches to improve our understanding and management of IBD.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Plattner, C., Sturm, G., Kuehl, A. A., Atreya, R., Carollo, S., Gronauer, R., Rieder, D., Guenther, M., Ormanns, S., Manzl, C., Meneghetti, A. R., Hegazy, A., Patankar, J., Carrero, Z. I., TRR241 IBDome Consortium,, Neurath, M. F., Kather, J. N., Becker, C., Siegmund, B., Trajanoski, Z.. 2025-03-26. IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases. https://doi.org/10.1101/2025.03.26.645544
Cite the original work for its findings. Save a collection to share your selection of sources.